Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson's disease genetically related mutants.

Tosatto L, Horrocks MH, Dear AJ, Knowles TP, Dalla Serra M, Cremades N, Dobson CM, Klenerman D.

Sci Rep. 2015 Nov 19;5:16696. doi: 10.1038/srep16696.

[Dopamine receptor agonists: new forms and new possibilities in the treatment of Parkinson's disease].

Katunina EA, Titova NV, Bezdolny YN, Shykkerimov RK, Gasanov MG, Burd SG, Lebedeva AV, Boiko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(5):34-40. Russian.

James Parkinson's essay on the shaking palsy.

Donaldson IM.

J R Coll Physicians Edinb. 2015 Mar;45(1):84-86. doi: 10.4997/JRCPE.2015.118. No abstract available.

Structural covariance networks of striatum subdivision in patients with Parkinson's disease.

Chou KH, Lin WC, Lee PL, Tsai NW, Huang YC, Chen HL, Cheng KY, Chen PC, Wang HC, Lin TK, Li SH, Lin WM, Lu CH, Lin CP.

Hum Brain Mapp. 2015 Apr;36(4):1567-84. doi: 10.1002/hbm.22724.

[Parkinson syndromes: aspects of social medical care].

Bujan B, Ginzburg E, Oertel WH, Bürk K.

Rehabilitation (Stuttg). 2015 Apr;54(2):81-5. doi: 10.1055/s-0034-1394444. German.

Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.

Schulz-Schaeffer WJ, Margraf NG, Munser S, Wrede A, Buhmann C, Deuschl G, Oehlwein C.

Mov Disord. 2015 Mar;30(3):368-72. doi: 10.1002/mds.26081.

Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation.

Zawada WM, Mrak RE, Biedermann J, Palmer QD, Gentleman SM, Aboud O, Griffin WS.

Acta Neuropathol Commun. 2015 Feb 3;3:9. doi: 10.1186/s40478-015-0189-z.

A new quantitative method for evaluating freezing of gait and dual-attention task deficits in Parkinson's disease.

Chomiak T, Pereira FV, Meyer N, de Bruin N, Derwent L, Luan K, Cihal A, Brown LA, Hu B.

J Neural Transm (Vienna). 2015 Nov;122(11):1523-31. doi: 10.1007/s00702-015-1423-3.

Sex Differences in Clinical Features of Early, Treated Parkinson's Disease.

Augustine EF, Pérez A, Dhall R, Umeh CC, Videnovic A, Cambi F, Wills AM, Elm JJ, Zweig RM, Shulman LM, Nance MA, Bainbridge J, Suchowersky O.

PLoS One. 2015 Jul 14;10(7):e0133002. doi: 10.1371/journal.pone.0133002.

Artistic occupations are associated with a reduced risk of Parkinson's disease.

Haaxma CA, Borm GF, van der Linden D, Kappelle AC, Bloem BR.

J Neurol. 2015 Sep;262(9):2171-6. doi: 10.1007/s00415-015-7828-y.

Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease.

Farber NM, Perez-Lloret S, Gamzu ER.

Curr Top Med Chem. 2015;15(10):939-54. Review.

Habitual behavior and dopamine cell vulnerability in Parkinson disease.

Hernández LF, Redgrave P, Obeso JA.

Front Neuroanat. 2015 Aug 6;9:99. doi: 10.3389/fnana.2015.00099. No abstract available. Erratum in: Front Neuroanat. 2015;9:146.

Treadmill Training Improves Forward and Backward Gait in Early Parkinson Disease.

Tseng IJ, Yuan RY, Jeng C.

Am J Phys Med Rehabil. 2015 Oct;94(10):811-9. doi: 10.1097/PHM.0000000000000273.

Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).

Storch A, Schneider CB, Klingelhöfer L, Odin P, Fuchs G, Jost WH, Martinez-Martin P, Koch R, Reichmann H, Chaudhuri KR; NoMoFlu-PD study group., Ebersbach G.

J Neural Transm (Vienna). 2015 Dec;122(12):1673-84. doi: 10.1007/s00702-015-1437-x.

Effect of visual cues on the resolution of perceptual ambiguity in Parkinson's disease and normal aging.

Díaz-Santos M, Cao B, Mauro SA, Yazdanbakhsh A, Neargarder S, Cronin-Golomb A.

J Int Neuropsychol Soc. 2015 Feb;21(2):146-55. doi: 10.1017/S1355617715000065.